Jun 09, 2019 - Vertex Pharmaceuticals recently doubled down on its gene editing collaboration with CRISPR Therapeutics, but it's miles behind an arguably simpler solution.
May 11, 2019 - Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Ian Estepan - Senior Vice President, Chief of Staff and Corporate Affairs Douglas
May 10, 2019 - SRPT earnings call for the period ending March 31, 2019.
May 08, 2019 - Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 47.81% and 0.11%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
May 02, 2019 - The following slide deck was published by Sarepta Therapeutics, Inc. in conjunction with this event.
Apr 29, 2019 - Sarepta Therapeutics' (SRPT) Exondys 51 likely to drive first-quarter sales.
Apr 25, 2019 - Sarepta Therapeutics (SRPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Apr 23, 2019 - Want to invest like the great value investor? These stocks might appeal to you.
Apr 17, 2019 - Wave Life Sciences (WVE) announces final safety data from a phase I DMD study evaluating suvodirsen and provides design update for phase II/III stage development of the candidate.
Apr 08, 2019 - Gene therapy continues to be in focus given the recent spate of deals and acquisitions. We highlight four stocks, which have promising gene therapy candidates in their pipeline.